Manufacturing
Market Continuous by Roots Analysis




Recent advances in
the manufacturing technologies have prompted pharmaceutical companies to
consider shifting from the traditional multi-step, batch manufacturing
processes to faster, and relatively more efficient continuous manufacturing





Roots Analysis is pleased to
announce the publication of its recent study, titled, “Manufacturing Market
Continuous (Small Molecules and
Biologics), 2020 – 2030.”







The report features an extensive
study of the current market landscape and future opportunities for companies
with capabilities in continuous manufacturing (both innovator companies with
in-house expertise and contract manufacturers). It features an in-depth
analysis, highlighting the capabilities of various stakeholders engaged in this
domain. In addition to other elements, the study includes:


§ A
detailed assessment of the overall landscape of companies with capabilities for
continuous manufacturing


§
Elaborate profiles of
some of the key contract manufacturers active in the pharmaceutical and
biopharmaceutical continuous manufacturing market


§
An analysis of the
various partnerships related to continuous manufacturing, which have been
established since 2013


§
An analysis of the
expansions related to continuous manufacturing, which have been established
since 2013


§
An estimate of the
global, continuous manufacturing capacity, based on the capacities of various
industry stakeholders (as available on their respective company websites).


§
A study of the
various grants that have been awarded to research institutes engaged in
projects related to continuous manufacturing, between 2014 and 2019


§
An in-depth analysis
of the various patents that have been filed / granted related to continuous
manufacturing till 2019


§
Initiatives taken by
the leading pharmaceutical companies (in terms of revenues), covering both
partnered as well as in-house projects.


§
A review of the
companies offering modular facilities / modular cleanrooms


§
A case study of the
companies offering technologies / equipment


§
A case study on the
roadmap for the adoption of continuous manufacturing technique


§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)


§
Purpose of Manufacturing


§
In-House


§
Contract service


§
Scale of Operation


§
Commercial


§
Preclinical / Clinical


§
Type of Continuous
Manufacturing related Service


§
API Manufacturing


§
End Product
manufacturing


§
Type of Drug Molecule


§
Biologic


§
Small Molecule


§
Type of dosage form


§
Solid


§
Liquid


§
Key Geographical Regions



§
North America


§
Europe


§
Asia Pacific


To
Request for sample report - https://www.rootsanalysis.com/reports/308/request-sample.html





§
Transcripts of
interviews held with the following senior level representatives of stakeholder
companies


§
Andrea Adamo, Founder and Chief Executive Officer, Zaiput
Flow technologies


§
Bayan Takizawa, Co-Founder and Chief Business Officer,
CONTINUUS Pharmaceuticals


§
Nick Thomson, Senior Director Chemical Research and
Development, Pfizer


§
Himanshu Gadgil, Director and Chief Scientific Officer,
Enzene Biosciences


§
Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)


§
Ian Houson, Technical Project Manager, Continuous
Manufacturing and Crystallization, University of Strathclyde





Key
companies covered in the report


§
AbbVie Contract Manufacturing


§
Ajinomoto Bio-Pharma Services


§
Almac


§
Boehringer Ingelheim BioXcellence


§
Cambrex


§
CordonPharma


§
Hovione


§
Kaneka


§
Lonza


§
Patheon


§
SK biotek


§
WuXi AppTec





For
more information please click on the following link:


https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html





Other Offerings


1.
Pharmaceutical Contract Manufacturing
Market (2nd Edition), 2018-2028


2.
Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030


3.
China Pharmaceutical Contract Manufacturing Services Market, 2020-2030


4.
China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030





About Roots Analysis


Roots Analysis is one of the fastest
growing market research companies, sharing fresh and independent perspectives
in the bio-pharmaceutical industry. The in-depth research, analysis and
insights are driven by an experienced leadership team which has gained many
years of significant experience in this sector. If you’d like help with your
growing business needs, get in touch at info@rootsanalysis.com





Contact Information


Roots Analysis Private
Limited


Gaurav Chaudhary


+1 (415) 800 3415


ben.johnson@rootsanalysis.com


Facebook - https://www.facebook.com/RootsAnalysis


LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter
- https://twitter.com/RootsAnalysis